06:45 AM EDT, 10/14/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) reported fiscal Q3 adjusted earnings Tuesday of $2.80 per diluted share, up from $2.42 a year earlier.

Analysts polled by FactSet expected $2.76.

Reported sales for the quarter ended Sept. 28 were $23.99 billion, up from $22.47 billion a year earlier.

Analysts surveyed by FactSet expected $23.76 billion.

For 2025, the pharmaceuticals giant reiterated its adjusted EPS guidance to between $10.80 and $10.90 per share. It raised its annual reported sales guidance to $93.5 billion to $93.9 billion from $93.2 billion to $93.6 billion.

Analysts polled by FactSet expect non-GAAP EPS of $10.85 on revenue of $93.48 billion.

Shares of the company were up 0.6% in recent Tuesday premarket activity.